1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CYTEIR THERAPEUTICS INC

Cyteir Therapeutics Inc

XNAS: CYTT

Watchlist

Portfolio

Share


Insider Trading disclosures for Cyteir Therapeutics Inc

The latest disclosure was made by David Gaiero in Cyteir Therapeutics Inc where a trade of 2,373 Stock Option (Right to Buy) done was reported to US exchanges on Feb. 29, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
David Gaiero Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 2,373 83,052 - - Stock Option (Right to Buy)
Markus F. Renschler Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. 29 Feb 2024 12,607 1,094,820 - 1.7 21,306 Common Stock
Markus F. Renschler Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 6,304 220,648 - - Stock Option (Right to Buy)
Markus F. Renschler Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 2,537 0 - - Stock Option (Right to Buy)
Markus F. Renschler Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 12,607 226,952 - - Stock Option (Right to Buy)
Markus F. Renschler Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. 29 Feb 2024 6,304 1,103,661 - 1.7 10,654 Common Stock
Markus F. Renschler Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. 29 Feb 2024 2,537 1,097,357 - 1.2 3,044 Common Stock
David Gaiero Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. 29 Feb 2024 4,746 100,018 - 1.7 8,021 Common Stock
David Gaiero Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. 29 Feb 2024 3,239 95,272 - 1.7 5,442 Common Stock
David Gaiero Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. 29 Feb 2024 2,373 102,391 - 1.7 4,010 Common Stock
David Gaiero Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 3,239 16,196 - - Stock Option (Right to Buy)
David Gaiero Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 4,746 85,425 - - Stock Option (Right to Buy)
George M. Jean Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 14,150 0 - - Stock Option (Right to Buy)
George M. Jean Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. 14 Feb 2024 14,150 14,150 - 1.7 23,914 Common Stock
Sands Stephen Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. 09 Feb 2024 12,129 12,129 - 1.7 20,498 Common Stock
Sands Stephen Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2024 12,129 0 - - Stock Option (Right to Buy)
Thero F. John Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2024 12,828 0 - - Stock Option (Right to Buy)
Thero John F. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. 08 Feb 2024 12,828 22,828 - 1.7 21,679 Common Stock
Joseph S. Zakrzewski Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. 06 Feb 2024 14,150 227,439 - 1.7 23,914 Common Stock
S. Joseph Zakrzewski Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2024 14,150 0 - - Stock Option (Right to Buy)
Gaiero David Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. 11 Dec 2023 1,620 89,660 - 1.7 2,722 Common Stock
David Gaiero Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2023 1,620 19,435 - - Stock Option (Right to Buy)
F. Renschler Markus Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2023 6,304 239,559 - - Stock Option (Right to Buy)
Markus Renschler F. Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2023 2,536 2,537 - - Stock Option (Right to Buy)
Renschler Markus F. Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. 11 Dec 2023 2,536 1,082,213 - 1.2 3,043 Common Stock
Gaiero David Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2023 2,373 90,171 - - Stock Option (Right to Buy)
Markus Renschler F. Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. 11 Dec 2023 6,304 1,079,677 - 1.7 10,654 Common Stock
David Gaiero Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.69 per share. 11 Dec 2023 2,373 92,033 - 1.7 4,010 Common Stock
Racquel Bracken Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 14,150 14,150 - - Stock Option (Right to Buy)
Jeffrey Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 14,150 14,150 - - Stock Option (Right to Buy)
David Gaiero Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 113,900 113,900 - - Stock Option (Right to Buy)
David Gaiero Chief Financial Officer Grant, award, or other acquisition of securities at price $ 1.49 per share. 03 Feb 2023 5,000 9,100 - 1.5 7,450 Common Stock
John F. Thero Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 12,828 12,828 - - Stock Option (Right to Buy)
Joseph S. Zakrzewski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 14,150 14,150 - - Stock Option (Right to Buy)
Markus F. Renschler Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.49 per share. 03 Feb 2023 5,000 983,736 - 1.5 7,450 Common Stock
Markus F. Renschler Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 302,600 302,600 - - Stock Option (Right to Buy)
Jean M. George Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 14,150 14,150 - - Stock Option (Right to Buy)
Susan M. Molineaux Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 14,150 14,150 - - Stock Option (Right to Buy)
Adam M. Veness General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 96,100 96,100 - - Stock Option (Right to Buy)
Timothy Romberger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 14,150 14,150 - - Stock Option (Right to Buy)
Stephen Sands Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 12,129 12,129 - - Stock Option (Right to Buy)
Markus F. Renschler Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. 21 Dec 2022 106,345 948,299 - 1.0 109,535 Common Stock
Markus F. Renschler Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. 21 Dec 2022 30,437 978,736 - 1.2 36,524 Common Stock
Markus F. Renschler Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2022 106,345 0 - - Stock Option (Right to Buy)
Markus F. Renschler Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2022 30,437 32,973 - - Stock Option (Right to Buy)
Joseph S. Zakrzewski Director Purchase of securities on an exchange or from another person at price $ 1.61 per share. 12 May 2022 743 133,416 - 1.6 1,196 Common Stock
Joseph S. Zakrzewski Director Purchase of securities on an exchange or from another person at price $ 1.89 per share. 10 May 2022 49,406 131,673 - 1.9 93,377 Common Stock
Joseph S. Zakrzewski Director Purchase of securities on an exchange or from another person at price $ 1.70 per share. 10 May 2022 1,000 132,673 - 1.7 1,700 Common Stock
John F. Thero Director Purchase of securities on an exchange or from another person at price $ 2.00 per share. 10 May 2022 10,000 10,000 - 2 20,000 Common Stock
Adam M. Veness General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 177,000 177,000 - - Stock Option (Right to buy)
John Paul Secrist Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 42,000 42,000 - - Stock Option (Right to Buy)
Stephen Sands Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 28,300 28,300 - - Stock Option (Right to Buy)
Timothy Romberger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 14,150 14,150 - - Stock Option (Right to Buy)
Janwillem Naesens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 14,150 14,150 - - Stock Option (Right to Buy)
Racquel Bracken Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 14,150 14,150 - - Stock Option (Right to Buy)
Jeffrey Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 2,358 2,358 - - Stock Option (Right to Buy)
David Gaiero Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 23,000 23,000 - - Stock Option (Right to Buy)
Andrew Gengos Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 35,000 35,000 - - Stock Option (Right to Buy)
Susan M. Molineaux Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 14,150 14,150 - - Stock Option (Right to Buy)
Jean M. George Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 14,150 14,150 - - Stock Option (Right to Buy)
Markus F. Renschler Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 106,200 106,200 - - Stock Option (Right to Buy)
Joseph S. Zakrzewski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 14,150 14,150 - - Stock Option (Right to Buy)
John F. Thero Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 28,300 28,300 - - Stock Option (Right to Buy)
Joseph S. Zakrzewski Director Purchase of securities on an exchange or from another person at price $ 9.85 per share. 23 Dec 2021 601 82,267 - 9.9 5,920 Common Stock
Joseph S. Zakrzewski Director Purchase of securities on an exchange or from another person at price $ 9.87 per share. 23 Dec 2021 200 81,367 - 9.9 1,974 Common Stock
Joseph S. Zakrzewski Director Purchase of securities on an exchange or from another person at price $ 9.97 per share. 23 Dec 2021 200 81,567 - 10.0 1,994 Common Stock
Joseph S. Zakrzewski Director Purchase of securities on an exchange or from another person at price $ 10.18 per share. 23 Dec 2021 99 81,666 - 10.2 1,008 Common Stock
David Gaiero Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. 20 Dec 2021 4,100 4,100 - 1.7 6,888 Common Stock
David Gaiero Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Dec 2021 4,100 73,639 - - Stock Option (Right to Buy)
Joseph S. Zakrzewski Director Purchase of securities on an exchange or from another person at price $ 9.88 per share. 17 Dec 2021 200 81,167 - 9.9 1,976 Common Stock
Joseph S. Zakrzewski Director Purchase of securities on an exchange or from another person at price $ 11.12 per share. 15 Dec 2021 1,700 80,967 - 11.1 18,904 Common Stock
Joseph S. Zakrzewski Director Purchase of securities on an exchange or from another person at price $ 10.47 per share. 15 Dec 2021 2,000 79,267 - 10.5 20,940 Common Stock
Jeffrey Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2021 28,300 28,300 - - Stock Option (Right to Buy)
Timothy Romberger Director 22 Jun 2021 69,503 0 - - Series A Convertible Preferred Stock
Janwillem Naesens Director 22 Jun 2021 1,109,368 0 - - Series C Convertible Preferred Stock
Timothy Romberger Director 22 Jun 2021 79,060 369,448 - - Common Stock
Timothy Romberger Director 22 Jun 2021 200,000 0 - - Series B Convertible Preferred Stock
Joseph S. Zakrzewski Director 22 Jun 2021 200,000 0 - - Series B Convertible Preferred Stock
Joseph S. Zakrzewski Director 22 Jun 2021 58,671 58,671 - - Common Stock
Jean M. George Director 22 Jun 2021 7,500,000 0 - - Series B Convertible Preferred Stock
Jean M. George Director 22 Jun 2021 2,444,268 2,444,268 - - Common Stock
Jean M. George Director 22 Jun 2021 832,026 0 - - Series C Convertible Preferred Stock
Janwillem Naesens Director 22 Jun 2021 3,259,026 3,259,026 - - Common Stock
Janwillem Naesens Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 22 Jun 2021 277,777 3,536,803 - 18 4,999,986 Common Stock
Janwillem Naesens Director 22 Jun 2021 10,000,000 0 - - Series B Convertible Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters